Itolizumab

Itolizumab
Monoclonal antibody
Type	Whole antibody
Source	Humanized
Target	CD6
Clinical data
Trade names	Alzumab
ATC code	none;
Legal status
Legal status	Approved in India;
Identifiers
CAS Number	1116433-11-4 ;
ChemSpider	none;
UNII	XQQ2RHV14N;
KEGG	D12426;
	(what is this?) (verify)

Itolizumab (INN, trade name Alzumab) is a 'first in class' humanized IgG1 monoclonal antibody developed by Biocon and the Center of Molecular Immunology (CIM), Havana.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.